HC Wainwright Reiterates Buy Rating for Viking Therapeutics (NASDAQ:VKTX)
HC Wainwright reaffirmed their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. HC Wainwright currently has a $102.00 target price on the biotechnology company’s stock. VKTX has been the topic of several other reports. Piper Sandler reduced their target price on Viking […]
HC Wainwright reaffirmed their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. HC Wainwright currently has a $102.00 target price on the biotechnology company’s stock. VKTX has been the topic of several other reports. Piper Sandler reduced their target price on Viking […]
